Completed NA INTERVENTIONAL 2-arm
NCT06035614
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Sponsor: Clarteis
Interventions
Tacrolimus ointment exciplex
Updated 4 times since 2023 Last updated: Sep 11, 2023 Started: Oct 1, 2022 Primary completion: May 1, 2023 Completion: Jul 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Autoimmune Diseases and Dermatologic Disease, this trial is completed. The trial is conducted by Clarteis and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
First recorded
Oct 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Clarteis
Data source: Clarteis
For direct contact, visit the study record on ClinicalTrials.gov .